University of Zurich
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Private
- Established
- 1833-04-29
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.uzh.ch
A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab
Phase 2
Completed
- Conditions
- Oropharyngeal CancerHypopharyngeal CancerLaryngeal Cancer
- Interventions
- First Posted Date
- 2011-09-16
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 68
- Registration Number
- NCT01435252
- Locations
- 🇨🇭
University Hospital, Zurich, Switzerland
Practicability of Gliding Aids for Medical Compression Stockings
Phase 4
Completed
- Conditions
- Chronic Venous InsufficiencyPost-thrombotic Syndrome
- Interventions
- Device: Gliding aids for medical compression stockings
- First Posted Date
- 2011-09-13
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 40
- Registration Number
- NCT01432795
- Locations
- 🇨🇭
Department of Dermatology, University Hospital of Zurich, Switzerland, Zurich, Switzerland
Steroids Added to Dithranol and Narrow Band UVB(Ultraviolet B) (UVBnb) in Psoriasis
Phase 4
Withdrawn
- Conditions
- Psoriasis
- Interventions
- Drug: Steroid active treatment
- First Posted Date
- 2011-09-07
- Last Posted Date
- 2018-07-19
- Lead Sponsor
- University of Zurich
- Registration Number
- NCT01429870
- Locations
- 🇨🇭
University Hospital Dermatology Department, Zurich, Switzerland
Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?
Completed
- Conditions
- Fasciitis, PlantarPeriarthritis CalcareaAchillodyniaEpikondylopathia Humeri /Radii
- First Posted Date
- 2011-09-07
- Last Posted Date
- 2015-06-03
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 36
- Registration Number
- NCT01429883
- Locations
- 🇨🇭
University Hospital, Zurich, Switzerland
Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension
Phase 2
Completed
- Conditions
- Pulmonary HypertensionBreathing-Related Sleep Disorder
- Interventions
- Drug: Placebo tabletOther: Supplemental oxygenProcedure: Non-invasive ventilationOther: Room air
- First Posted Date
- 2011-09-01
- Last Posted Date
- 2012-12-12
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 23
- Registration Number
- NCT01427192
- Locations
- 🇨🇭
Respiratory Clinic, University Hospital of Zurich, Zurich, Switzerland
The Swiss Glucose Variability Study
Phase 4
- Conditions
- Type 2 Diabetes
- First Posted Date
- 2011-08-31
- Last Posted Date
- 2011-08-31
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 50
- Registration Number
- NCT01426737
- Locations
- 🇨🇭
Universitiy Hospital, Zurich, Switzerland
Phase II Study to Standardize Allergen Extracts: Determination of Biological Activity in HEP Units
Phase 2
Terminated
- Conditions
- Allergy
- Interventions
- Other: Allergen extracts
- First Posted Date
- 2011-08-09
- Last Posted Date
- 2011-08-09
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 160
- Registration Number
- NCT01412528
- Locations
- 🇨🇭
Clinical Trials Center, Zurich, Switzerland
Effect Of Intravenous Iron Versus Placebo On Muscle Oxidative Capacity And Physical Performance in Premenopausal Women
Phase 4
Completed
- Conditions
- Non Anemic Patients With Iron Deficiency (Low Ferritin Value)
- Interventions
- Drug: intravenous iron carboxymaltose
- First Posted Date
- 2011-06-16
- Last Posted Date
- 2021-05-07
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 24
- Registration Number
- NCT01374776
- Locations
- 🇨🇭
University Hospital Zurich, Clinic and Policlinic of Internal Medicine, Zurich, ZH, Switzerland
Swiss Study on Spider Bites
Completed
- Conditions
- Spider Bite
- First Posted Date
- 2011-05-18
- Last Posted Date
- 2013-10-07
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 17
- Registration Number
- NCT01355744
- Locations
- 🇨🇭
Praxis Dr. med. Markus Gnaedinger, Steinach, SG, Switzerland
1H-19F Gastrointestinal MRI in Health and IBS
Suspended
- Conditions
- Irritable Bowel Syndrome
- Interventions
- Device: 19F capsuleDietary Supplement: sterculia
- First Posted Date
- 2011-05-05
- Last Posted Date
- 2015-04-09
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 24
- Registration Number
- NCT01347918
- Locations
- 🇨🇭
University Hospital Zurich, Gastroenterology, Zurich, Switzerland
© Copyright 2025. All Rights Reserved by MedPath